Delta Electronics revealed on June 18 its intention to acquire shares worth up to US$11.78 million in ACT Genomics Holdings Company Limited, a prominent cancer testing firm in Asia. The goal is to attain over 90% ownership, contingent on fulfilling...
The article requires paid subscription. Subscribe Now